The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
A randomized study of solriamfetol for excessive sleepiness in narcolepsy
Open accessAbstract
Objective: Solriamfetol (JZP‐110) is a selective dopamine and norepinephrine reuptake inhibitor with wake‐promoting effects. This phase 3 study (NCT02348593) evaluated the safety and efficacy of solriamfetol in narcolepsy. Methods: Patients with narcolepsy with mean sleep latency <25 minutes on the Maintenance of Wakefulness Test (MWT), Epworth Sleepiness Scale (ESS) score ≥10, and usual nightly sleep ≥6 hours were randomized to solriamfetol 75, 150, or 300 mg, or placebo for 12 weeks. Coprimary endpoints were change from baseline to week 12 in MWT and ESS. Improvement on the Patient Global Impression of Change (PGI‐C) was the key secondary endpoint. Results: Safety and modified intention‐to‐treat populations included 236 and 231 patients, respectively. Solriamfetol 300 and 150 mg were positive on both coprimary endpoints. Least squares mean (standard error [SE]) changes from baseline were 12.3 (SE = 1.4) and 9.8 (SE = 1.3) minutes for solriamfetol 300 and 150 mg on the MWT, respectively, versus 2.1 (SE = 1.3) minutes for placebo, and −6.4 (SE = 0.7) for 300 mg and −5.4 (SE = 0.7) for 150 mg on the ESS versus −1.6 (SE = 0.7) for placebo (all p < 0.0001). At week 12, higher percentages of patients treated with solriamfetol 150 mg (78.2%) and 300 mg (84.7%) reported PGI‐C improvement relative to placebo (39.7%; both p < 0.0001). Adverse events ≥5% across all solriamfetol doses included headache (21.5%), nausea (10.7%), decreased appetite (10.7%), nasopharyngitis (9.0%), dry mouth (7.3%), and anxiety (5.1%). Interpretation: Solriamfetol has the potential to be an important therapeutic option for the treatment of impaired wakefulness and excessive sleepiness in patients with narcolepsy. ANN NEUROL 2019;85:359–370.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale
Johns, M. W. (1991) · Sleep · doi:10.1093/sleep/14.6.540 · Cited by 17,364
Analysis of Incomplete Multivariate Data
Schafer, J. L. (1997) · doi:10.1201/9781439821862 · Cited by 6,012
Posner, K., Brown, G. K., Stanley, B., Brent, D. A., Yershova, K. V., Oquendo, M. A., Currier, G. W., Melvin, G. A., Greenhill, L., Shen, S., et al. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10111704 · Cited by 5,157
The International Classification of Sleep Disorders: Diagnostic and Coding Manual
Daroff, R. B. (1991) · Neurology · doi:10.1212/wnl.41.1.160 · Cited by 5,014
Littner, M. R., Kushida, C., Wise, M., G. Davila, D., Morgenthaler, T., Lee-Chiong, T., Hirshkowitz, M., Loube, D. L., Bailey, D., Berry, R. B., et al. (2005) · Sleep · doi:10.1093/sleep/28.1.113 · Cited by 1,142
Pattern-Mixture Models for Multivariate Incomplete Data
Little, R. J. A. (1993) · Journal of the American Statistical Association · doi:10.1080/01621459.1993.10594302 · Cited by 1,035
Rothman, R. B., Baumann, M. H., Dersch, C. M., Romero, D. V., Rice, K. C., Carroll, F. I., & Partilla, J. S. (2001) · Synapse · doi:10.1002/1098-2396(20010101)39:1<32::aid-syn5>3.0.co;2-3 · Cited by 938
Dauvilliers, Y., Arnulf, I., & Mignot, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60237-2 · Cited by 725
Self-citationRandomized trial of modafinil for the treatment of pathological somnolence in narcolepsy
Fry, & US Modafinil in Narcolepsy Multicenter Study Group (1998) · Annals of Neurology · doi:10.1002/ana.410430115 · Cited by 396
Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial
Dauvilliers, Y., Bassetti, C., Lammers, G. J., Arnulf, I., Mayer, G., Rodenbeck, A., Lehert, P., Ding, C.-L., Lecomte, J.-M., & Schwartz, J.-C. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70225-4 · Cited by 362
Self-citationRandomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy
US Modafinil in Narcolepsy Multicenter Study Group (2000) · Neurology · doi:10.1212/wnl.54.5.1166 · Cited by 362
Broughton, R. J., Fleming, J. A. E., George, C. F. P., Hill, J. D., Kryger, M. H., Moldofsky, H., Montplaisir, J. Y., Morehouse, R. L., Moscovitch, A., & Murphy, W. F. (1997) · Neurology · doi:10.1212/wnl.49.2.444 · Cited by 288
Sleep disorders, medical conditions, and road accident risk
Smolensky, M. H., Di Milia, L., Ohayon, M. M., & Philip, P. (2011) · Accident Analysis & Prevention · doi:10.1016/j.aap.2009.12.004 · Cited by 237
Sodium Oxybate Improves Excessive Daytime Sleepiness in Narcolepsy
Black, J., & Houghton, W. C. (2006) · Sleep · doi:10.1093/sleep/29.7.939 · Cited by 234
Self-citationHarsh, J. R., Hayduk, R., Rosenberg, R., Wesnes, K. A., Walsh, J. K., Arora, S., Niebler, G. E., & Roth, T. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x100050 · Cited by 195
Maski, K. P., Steinhart, E., Williams, D. N., Scammell, T. E., Flygare, J., McCleary, K., & Gow, M. (2017) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.6494 · Cited by 170
Health-related quality of life in patients with narcolepsy
Dodel, R., Peter, H., Spottke, A., Noelker, C., Althaus, A., Siebert, U., Walbert, T., Kesper, K., Becker, H. F., & Mayer, G. (2007) · Sleep Medicine · doi:10.1016/j.sleep.2006.10.010 · Cited by 165
Self-citationClinical and practical considerations in the pharmacologic management of narcolepsy
Thorpy, M. J., & Dauvilliers, Y. A. (2014) · Sleep Medicine · doi:10.1016/j.sleep.2014.10.002 · Cited by 147
Self-citationA randomized trial of the long-term, continued efficacy and safety of modafinil in narcolepsy
Moldofsky, H. (2000) · Sleep Medicine · doi:10.1016/s1389-9457(99)00014-3 · Cited by 129
Narcolepsy: genetic predisposition and neuropharmacological mechanisms
Nishino, S., Okura, M., & Mignot, E. J.-M. (2000) · Sleep Medicine Reviews · doi:10.1053/smrv.1999.0069 · Cited by 113
Treatment Options for Narcolepsy
Barateau, L., Lopez, R., & Dauvilliers, Y. A. (2016) · CNS Drugs · doi:10.1007/s40263-016-0337-4 · Cited by 113
Self-citationThe Burden of Narcolepsy Disease (BOND) study: health-care utilization and cost findings
Black, J. E., Reaven, N. L., Funk, S. E., McGaughey, K. J., Ohayon, M. M., Guilleminault, C., Ruoff, C. M., & Mignot, E. J.-M. (2014) · Sleep Medicine · doi:10.1016/j.sleep.2014.02.001 · Cited by 103
Self-citationIngravallo, F., Gnucci, V., Pizza, F., Vignatelli, L., Govi, A., Dormi, A., Pelotti, S., Cicognani, A., Dauvilliers, Y. A., & Plazzi, G. (2012) · Sleep Medicine · doi:10.1016/j.sleep.2012.08.002 · Cited by 95
Self-citationModafinil as a Catecholaminergic Agent: Empirical Evidence and Unanswered Questions
Wisor, J. P. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00139 · Cited by 93
Baladi, M. G., Forster, M. J., Gatch, M. B., Mailman, R. B., Hyman, D. L., Carter, L. P., & Janowsky, A. J. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.248120 · Cited by 92
Self-citationCar Crashes and Central Disorders of Hypersomnolence: A French Study
Pizza, F., Jaussent, I., Lopez, R., Pesenti, C., Plazzi, G., Drouot, X., Leu-Semenescu, S., Beziat, S., Arnulf, I., & Dauvilliers, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129386 · Cited by 83
Self-citationDosing Regimen Effects of Modafinil for Improving Daytime Wakefulness in Patients With Narcolepsy
Schwartz, J. R. L., Feldman, N. T., Bogan, R., Nelson, M. T., & Hughes, R. J. (2003) · Clinical Neuropharmacology · doi:10.1097/00002826-200309000-00009 · Cited by 78
Ruoff, C. M., Swick, T. J., Doekel, R. C., Emsellem, H. A., Feldman, N. T., Rosenberg, R. P., Bream, G., Khayrallah, M. A., Lü, Y., & Black, J. E. (2016) · SLEEP · doi:10.5665/sleep.5968 · Cited by 78
Self-citationModafinil for narcolepsy: systematic review and meta-analysis.
Golicki, D., Bała, M. M., Niewada, M., & Wierzbicka, A. (2010) · PubMed · Cited by 73
Effect of oral JZP-110 (ADX-N05) treatment on wakefulness and sleepiness in adults with narcolepsy
Bogan, R., Feldman, N. T., Emsellem, H. A., Rosenberg, R. P., Lü, Y., Bream, G., Khayrallah, M. A., & Lankford, D. A. (2015) · Sleep Medicine · doi:10.1016/j.sleep.2015.05.013 · Cited by 72
Self-citationEffect of psychostimulants on blood pressure profile and endothelial function in narcolepsy
Bosco, A., Lopez, R., Barateau, L., Chenini, S., Pesenti, C., Pépin, J., Jaussent, I., & Dauvilliers, Y. A. (2018) · Neurology · doi:10.1212/wnl.0000000000004911 · Cited by 69
Self-citationUse of modafinil in the treatment of narcolepsy: A long term follow-up study
Besset, A., Chetrit, M., Carlander, B., & Billiard, M. M. (1996) · Neurophysiologie Clinique · doi:10.1016/0987-7053(96)81535-8 · Cited by 64
How to Keep the Brain Awake? The Complex Molecular Pharmacogenetics of Wake Promotion
Hasan, S., Pradervand, S., Ahnaou, A., Drinkenburg, W. H. I. M., Tafti, M., & Franken, P. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.3 · Cited by 58
Erman, M. K., Emsellem, H. A., Black, J. E., Mori, F., & Mayer, G. (2017) · Sleep Medicine · doi:10.1016/j.sleep.2017.07.015 · Cited by 25
Self-citation
Cited by
Narcolepsy — clinical spectrum, aetiopathophysiology, diagnosis and treatment
Bassetti, C. L. A., Adamantidis, A., Burdakov, D., Han, F., Gay, S., Kallweit, U., Khatami, R., Koning, F., Kornum, B. R., Lammers, G. J., et al. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0226-9 · Cited by 646
Self-citationSchweitzer, P. K., Rosenberg, R., Zammit, G. K., Gotfried, M., Chen, D., Carter, L. P., Wang, H., Lu, Y., Black, J., Malhotra, A., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201806-1100oc · Cited by 320
Self-citation
Metadata
- Authors
- Thorpy, M. J., Shapiro, C., Mayer, G., Corser, B. C., Emsellem, H., Plazzi, G., Chen, D., Carter, L. P., Wang, H., Lu, Y., Black, J., & Dauvilliers, Y.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2019-02-28
- Volume
- 85
- Issue
- 3
- Pages
- 359-370
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2914272431
- Cited by
- 327
- References
- 36
- FWCI
- 35.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.